Table 2.
Pathological features of 7 patients with Pancreatic Ductal Adenocarcinoma included in the immunohistochemistry analysis
| Age | Gender | Tumour type | Tumour Size (cm) | Tumour Grading | Tumour stage | Margins of resection | |
|---|---|---|---|---|---|---|---|
| 1 V-15660 | 78 | m | PDAC | 3.05 | G2-G3 | IIB | R1 |
| 1 M-17396 | 69 | m | Mucinous PDAC | 3 | G1 | IIB | R0 |
| 1 M-17536 | 53 | f | PDAC | 3 | G2-G3 | IIA | R0 |
| 1 T-17785 | 65 | m | PDAC | 3 | G2-G3 | IIB | R0 |
| 193551-10 | 73 | m | PDAC | 1,8 | G1 | IIB | R0 |
| I2011-010518 | 51 | f | PDAC | 2,5 | G2 | IIB | R0 |
| I2012-016339 | 78 | f | PDAC | 2,4 | G2 | IIB | R0 |
G1: well differentiated; G2: moderately differentiated; G3: poorly differentiated. R0: negative resection margins; R1:microscopic positive resection margins. Tumor stage sec. AJCC 2010.